Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...
News-Medical.Net on MSN8h
Combination of RAS inhibition and immunotherapy provides breakthrough for pancreatic cancerAdding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...
News-Medical.Net on MSN4d
Ovarian cancer mutations across populations show similarities and unique differencesAn extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at ...
An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at ...
Understanding your tumor biology is key to finding the right treatment for pancreatic cancer. Identifying mutations, or changes in a [...] READ MORE ...
Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...
Firefighters may face a heightened risk of developing brain cancer due to their persistent exposure to certain chemicals, a ...
Health and Me on MSN16h
Do You Have A Cancer Gene? Here’s What You Need To Do NextGenetic testing helps identify hereditary cancer risks, with 5-10% of cancers caused by inherited mutations. Early detection ...
Verywell Health on MSN6h
The 3 Types of Ovarian Cancer and How They Are DifferentThere are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...
New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.
TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback